Compare Enveric Biosciences Inc (ENVB) vs Materials Select Sector SPDR Fund (XLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Materials Select Sector SPDR Fund — how do they compare? Enveric Biosciences Inc trades at $1.39 (market cap $5.32M), while Materials Select Sector SPDR Fund trades at $50.62. The key difference: Materials Select Sector SPDR Fund is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | XLB | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | — |
52-Week High | $17.40 | $53.62 |
52-Week Low | $1.28 | $42.23 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
XLB trades at $50.69, up 0.1% with a bearish technical signal from moving averages and neutral oscillators. The materials sector ETF faces mixed sentiment, with Seeking Alpha rating it 'Hold' due to limited upside after recent gains. Support sits at $50, resistance at $51. A dividend of $0.19 is scheduled for June 2026, but key financial ratios like P/E and ROE are unavailable in the current data.
Outlook is cautious; geopolitical risks and inflation may pressure materials stocks, while infrastructure trends offer support. Analyst consensus leans neutral, with earnings growth potential offset by high valuations. Risks include sector concentration and macroeconomic shifts, requiring careful monitoring for entry points.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Materials Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: chemicals; metals and mining; paper and forest products; containers and packaging; and construction materials. The fund is non-diversified.
Read more on XLB →
